Intravitreal bevacizumab followed by laser photocoagulation for retinal capillary hemanginoblastomas

Eylem Yaman Pinarci, Humeyra Karacal, Berna Demirel

Research output: Contribution to journalArticle

Abstract

Purpose: To report a patient with retinal capillary hemangioblastomas associated with Von Hippel-Lindau syndrome who achieved long-term visual improvement with single intravitreal bevacizumab injection followed by laser photocoagulation. Methods: Intravitreal bevacizumab injection was performed in a 17-year-old girl with bilateral multiple retinal capillary hemangioblastomas. Laser photocoagulation was then performed to augment the initial response to bevacizumab. The visual acuity, fundus photography, fundus fluorescein angiography, and ocular coherence tomography were obtained at each visit. The patient was followed-up for 3 years. Results: Two weeks after injection, the macular edema and exudation significantly decreased with an improvement in the visual acuity. Laser photocoagulation performed 2 weeks after the intravitreal bevacizumab injection provided further regression of exudation and scarring of the hemangioblastomas. No further intervention was required, and the visual acuity returned to baseline at the third year of follow-up. Conclusion: Combined intravitreal bevacizumab with laser photocoagulation is a viable option in retinal capillary hemangioblastomas associated with Von Hippel-Lindau syndrome.

Original languageEnglish
Pages (from-to)76-79
Number of pages4
JournalRetinal Cases and Brief Reports
Volume6
Issue number1
DOIs
StatePublished - Dec 1 2012

Fingerprint Dive into the research topics of 'Intravitreal bevacizumab followed by laser photocoagulation for retinal capillary hemanginoblastomas'. Together they form a unique fingerprint.

  • Cite this